COLL - Company ID 0001267565
The table below shows COLLEGIUM PHARMACEUTICAL, INC's cash flow statement by quarter, as reported in the company's quarterly filings. All figures are in US dollars; negative values appear in red.
| Line item | Q2 2026 | Q1 2026 | Q2 2025 | Q1 2025 | Q1 2024 | Q1 2023 |
|---|---|---|---|---|---|---|
| Operating cash flow | - | $57.11M | - | $55.40M | $61.94M | $27.67M |
| Capital expenditure | - | $270.00K | - | $798.00K | $568.00K | $176.00K |
| Investing cash flow | - | $1.63M | - | -$9.68M | -$18.13M | -$176.00K |
| Dividends paid | - | - | - | - | - |
COLLEGIUM PHARMACEUTICAL, INC reported operating cash flow of $329.32M for fiscal year 2025. That is up 60.7% from $204.98M in fiscal 2024. Over the 10 fiscal years shown, operating cash flow grew from -$75.05M (FY 2016) to $329.32M. Figures come from the company's audited annual reports as filed with the SEC.
Data parsed from SEC EDGAR XBRL filings. See the full market cap rankings.
| - |
| Stock buybacks | $0.00 | - | $25.10M | - | - | - |
| Financing cash flow | - | -$21.34M | - | -$25.24M | -$54.15M | $68.30M |